Key result
Among 16 patients with idiopathic acute massive pulmonary thromboembolism, 44% (7 patients) were associated with antipsychotic drug use, including risperidone and conventional phenothiazines.
Why the study?
Are antipsychotic medications such as risperidone and conventional phenothiazines associated with acute massive pulmonary thromboembolism in otherwise healthy patients?
Observational (n=47)
No
Are antipsychotic medications such as risperidone and conventional phenothiazines associated with acute massive pulmonary thromboembolism in otherwise healthy patients?
Risperidone and conventional phenothiazines may be associated with an increased risk of acute massive pulmonary thromboembolism, potentially due to increased coagulability from 5HT2A receptor affinity.
Answers are grounded in this paper and cite their sources.
Antipsychotics may associate with idiopathic massive PE in case series; hypothesis-generating, requires prospective confirmation before any clinical inference.
To assess the contribution of antipsychotic medication in Japanese patients suffering acute massive pulmonary thromboembolism, records of patients with idiopathic pulmonary thromboembolism associated with antipsychotic medication who were seen in a Japanese Emergency Center from January 1996 to December 2000 were reviewed. Age, gender, physical status, clinical presentation, antiphospholipid antibody, outcome, psychiatric profile, and antipsychotic medication use were examined. Seven patients had acute pulmonary thromboembolism associated with antipsychotic drug use, representing 44% of all patients with idiopathic pulmonary thromboembolism. The 7 patients developed symptoms in the early morning. More women than men were affected. In 5 cases, chlorpromazine and other phenothiazines had been prescribed, whereas in 2 cases, risperidone, a mixed serotonin 5HT(2A) and dopamine D(2) receptor antagonist, had been taken for 40 days and 6 days, respectively. In 4 cases, including the patients taking risperidone, antiphospholipid antibodies were not present. Although statistically significant conclusions can not be drawn from this study, the data suggest that patients receiving risperidone, as well as conventional phenothiazines, are at risk for acute pulmonary thromboembolism, even if otherwise healthy. Strong affinity for the 5HT(2A) receptor of the novel antipsychotic may increase coagulability and the risk of thromboembolism.
No takes yet. Share an insight, caveat, or question.
Kamijo et al. (2002) conducted an observational in Acute massive pulmonary thromboembolism (n=47). Antipsychotic medication (risperidone and conventional phenothiazines) was evaluated on Proportion of idiopathic pulmonary thromboembolism cases associated with antipsychotic drug use. Among 16 patients with idiopathic acute massive pulmonary thromboembolism, 44% (7 patients) were associated with antipsychotic drug use, including risperidone and conventional phenothiazines.
Synapse has enriched 10 related papers. Consider them for comparative context: